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Abstract 
We investigated the postnatal ontogeny of opioid receptors 
in rat brain under assay conditions which, when combined 
with computerized analysis, effectively reflect the develop- 
mental profile of high affinity binding to A, 6, and K subpopu- 
lations. Concentrations of CL sites were assessed with 
the selective ligand 3H-[o-ala2,mePhe4,gly-o15]enkephalin 
(DAGO). The other two sites were analyzed in binding assays 
with less selective radioligands but in the presence of spe- 
cific unlabeled ligands which suppress cross-reactivity. We 
utilized 3H-[D-ala2,D-leu5]enkephalin (DADL) in the presence 
of 10 nM DAGO to label 6 sites and 3H-ethylketocyclazocine 
(EKC) in the presence of 100 nM DADL + 100 nM [D- 
ala2,mePhe4,Met(0)o15]enkephalin to detect K receptors. After 
birth, the density (femtomoles per milligram of wet weight) 
of ~1 sites declined for several days and then rose sharply 
over the next 2 weeks, increasing P-fold by adulthood. Delta 
(6) sites appeared in the second week postnatal and in- 
creased more than 8-fold in the next 2 weeks. Levels of K 
receptors were relatively low at birth and increased slowly 
(Bfold, overall). Computerized analyses of binding data re- 
vealed that DAGO and DADL were binding to single popula- 
tions of sites throughout the postnatal period. DAGO and 
EKC affinities did not fluctuate in this period, whereas DADL 
affinities were low for the first week and then rose to adult 
levels. In summary, p, K, and 6 receptors exhibit differential 
postnatal developmental profiles. The former two are present 
at birth, whereas the latter appears in the second week. The 
postnatal increase for all three sites appear to be preceded 
by the previously demonstrated emergence of opioid pep- 
tides. 
Opioid receptors in the central nervous system of the rat, as 
detected by the specific binding of 3H-naloxone or 3H-naltrexone, 
are present at embryonic day 14, and their density increases until 
adulthood (Clendeninn et al., 1976; Coyle and Pert, 1976; Garcin 
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and Coyle, 1976; Kent et al., 1982; Wohltmann et al., 1982). In 
addition, the development of enkephalin-binding sites has been 
examined in attempts to demonstrate a correlation between the 
ontogeny of opioid-binding sites and the developmental patterns of 
endogenous opioid peptides (Coyle and Pert, 1976; Bayon et al., 
1979; Patey et al., 1980; Tsang et al., 1982). However, radioligands 
used in all of these studies were not entirely site specific. Considering 
the multiplicity of both opioid peptides and receptors, attempts to 
correlate their postnatal appearance require more specific binding 
assays. Recently, highly specific binding assays have been devel- 
oped that appear to eliminate the problem of cross-reactivity. For 
example, CL sites appear to be labeled almost exclusively with 3H-[~- 
ala*,mePhe“,gly-o15]enkephalin (DAGO) (Kosterlitz et al., 1981). Fur- 
thermore, site-specific cold ligands can be added to incubation 
mixtures containing less specific radioligands to improve selectivity 
for the target site (Chang et al., 1981; Gillan and Kosterlitz, 1982). 
By using 3H-ethylketocyclazocine (EKC) in the presence of excess 
amounts of unlabeled p- and b-specific ligands, putative K sites have 
been labeled. Likewise, 3H-[D-ala2,D-leu5]enkephalin (DADL) will ef- 
fectively label only 6 sites in the presence of an excess of unlabeled 
p-selective ligand. 
The objective of the present study was to re-examine the devel- 
opment of opioid receptors in rat brain by utilizing combinations of 
ligands cited above and analyzing the binding data with a weighted, 
nonlinear regression, model-fitting computer program. By this ap- 
proach, highly site-specific data can be obtained that more closely 
reflect the “true” developmental profile of these three opioid receptor 
types. The results reveal a differential development of cc, G,.and K 
sites with the 6 receptors not appearing until the second week 
postnatal. 
Materials and Methods 
Membrane preparation. Timed-pregnant Sprague-Dawley rats were ob- 
tained from Sasco Laboratories (St. Louis, MO) and maintained as previously 
described (Roth et al., 1980). Birth-dated pups (Cl2 hr) were sacrificed by 
decapitation at days 1, 4, 5, 7, 10, 14, 21, 28, or 35, and the brain was 
rapidly removed. Adult controls were sacrificed in a like manner. Whole brain 
was dissected into fore- and hindbrain by a coronal cut between the cerebrum 
and cerebellum, and the tissue for each age group (from one to eight 
animals) was pooled. Tissue was homogenized with a Polytron in 60 ml of 
50 mM Tris-HCI buffer, pH 7.4, at 4°C and was centrifuged at 20,000 x g 
for 25 min. The membranes were resuspended in fresh buffer (Dounce 
homogenizer) and incubated at 25°C for 20 min to remove endogenous 
opioid peptides, and the centrifugation was repeated. The pellet was taken 
up in sufficient Tris buffer (pH 7.4) to yield a final concentration of approxi- 
mately 1 mg of protein/ml. 
Binding assay. The final membrane homogenate was incubated with 
radioligand, a constant concentration of cold suppressor (if appropriate), and 
12 varying concentrations of cold ligand, producing a Scatchard analysis by 
the method of isotopic dilutton. The isotopic diluttons of either 0.1 nM 3H- 
DAGO (60 Ci/mmol; Amersham, Arlington Heights, IL), 1 nM DADL (19.4 Ci/ 
mmol; Amersham) in the presence of 10 nM DAGO, or 1 nM 3H-EKC (16.5 
Ci/mmol, New England Nuclear, Boston, MA) in the presence of 100 nM 
DADL and 100 nM [o-ala2,mePhe4,Met(0)o15]enkephalin (FK33824) were de- 
termined. The final volume of the incubation mixture for 3H-DAG0 and 3H- 
DADL was 0.5 ml, and that for 3H-EKC was 1 ml. Each assay was incubated 
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for 1 hr at 25°C prior to rapid filtration and collection of membrane-bound 
ligand on glass fiber filters (Whatman GF/B) as previously described (Roth 
et al., 1981). Protein concentations were determined by the method of Lowry 
et al. (1951) with bovine serum albumin as a standard. 
Computerized analysis. The curves produced by the isotopic dilution of 
radioligand were analyzed using the weighted, nonlinear, least squares 
regression LIGAND program (Munson and Rodbard, 1980). This iterative 
procedure constructs models of binding according to the laws of mass 
action for the interaction of multiple ligands with multiple binding sites. After 
determination of the binding affinity and capacity for each individual experi- 
ment with the LIGAND program, the results of the three or more experiments 
were then averaged to provide a weighted mean and SEM. All values, except 
where noted, represent the mean of three experiments performed in duplicate 
and calculated as follows: 
weighted mean = C( WiXi)/C( Wi) 
where Wi = l/SE?; weighted SE = l/m 
Results 
Binding affinities. Preliminary association experiments were per- 
formed using the assay conditions described above to ascertain 
that equilibrium binding was achieved within 1 hr for each radioligand. 
Isotopic dilution binding assays were then conducted at each age 
(Fig. l), and &,‘s were estimated (Table I). Computer analyses of 
3H-DAG0 and 3H-DADL binding revealed that a two-site model did 
not fit better than a one-site paradigm for all ages studied. Although, 
at times, the two- and one-site models fit equally well, the law of 
parsimony was invoked and the simpler model was accepted. 
In almost all cases for 3H-EKC binding, we observed that the two- 
site model fit better than a one-site model. However, there were a 
few experiments in which a one-site model fit the data as well. Since 
at all ages at least two of the three experiments fit the two-site 
model, we assume the anomalous data were due to experimental 
error that by chance resulted in a better fit for the one-site model. 
The high affinity EKC binding is designated as the K site on the 
basis of displacement studies performed in the adult with 1 nM 3H- 
EKC (+ 100 nM DAGO + 100 nM DADL) in the presence of dynorphin 
(1-13) (I& = 7 nM), SKF 10047 (I& = 60 nM), or phencyclidine 
(PCP) (~10% displacement by 1 to 1000 nM PCP) (data not shown). 
Also, the Kd values for 3H-EKC binding to the second site were 
approximately two orders of magnitude lower than for the high 
affinity binding site. 
The apparent Kd for 3H-DAG0 and 3H-EKC did not change (within 
experimental error as determined by analysis of variance) throughout 
the postnatal period. With respect to the binding of 3H-DADL before 
day 10 postnatal, we observed a small number of low affinity binding 
sites whereas, thereafter, we found only a high affinity form under 
our assay conditions. Because of the low affinity exhibited for 3H- 
DADL during early development, it appears that few high affinity 6 
sites are present in the first 10 days after birth. 
, 
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Binding capacities. All three opioid receptor types increased in 
density (femtomoles per milligram of wet weight) during postnatal 
development of the forebrain. From day 1 to adult, the number of 
both 3H-DAG0 and 3H-EKC binding sites doubled, and 3H-DADL 
receptor levels increased more than 8-fold (Fig. 2). Interestingly, 
levels of 3H-DAG0 binding sites initially declined after birth, resulting 
in a 32% reduction by day 4. This was followed by a rapid increase 
from day 7 through day 14, and adult levels were reached by day 
21. This result is similar to the Scatchard analyses by Pasternak et 
al. (1980), showing a 2.8-fold increase in 3H-morphine binding density 
for brain membranes of 2- and 14-day-old rats. 3H-DADL binding 
sites increased linearly from day 4 through day 28, when adult levels 
were reached. 3H-EKC binding revealed relatively sparse but mea- 
surable amounts of K sites in rat brain that rose slightly, peaking at 
day 35 and declining to adult levels. 
When the data are expressed as femtomoles per milligram of 
protein, the developmental profiles are altered somewhat (Fig. 3), 
reflecting a concurrent shift in the ratio of protein to wet weight. 
During the postnatal period this ratio displays a shallow sigmoidal 
curve, increasing from day 7 to day 21 and then leveling off (data 
not shown). Upon expressing the data in femtomoles per milligram 
of protein, a shift in the nadir of the CL sites is seen, and only the 
concentration of 3H-DADL binding sites increased over the entire 
time period. A statistically significant 32% reduction in P sites and 
no change in K sites were observed. 
Binding of 3H-EKC was also determined in the developing hind- 
brain (brainstem and cerebellum). On day 1 both fore- and hindbrain 
possessed equal amounts of these receptors (femtomoles per 
milligram of wet weight) (Fig. 2). However, by day 5, receptor levels 
changed, with the concentration of K sites in the hindbrain being 
about 2-fold higher. There appears to be no further fluctuation in 
density until day 14, whereupon hindbrain levels decrease and 
forebrain sites increase. 
Discussion 
Using site-specific assays and computer modeling, we demon- 
strated a distinct difference in timing and magnitude of development 
for the three types of opioid receptors examined (Figs. 2 and 3). 
Mu (CL) sites. 3H-DAG0 is thought to interact at the P site of adult 
rat brain membranes with a high degree of selectivity (Kosterlitz et 
al., 1981). Computerized analyses revealed that, in our hands, this 
ligand bound to a single high affinity population of receptors through- 
out the postnatal period. This was reinforced by the constancy of 
the estimated Kd for DAGO binding throughout postnatal develop- 
ment (Table I). These p receptors are present at birth in rat forebrain, 
and, after a decline in concentration during the first few days, they 
undergo a subsequent rapid increase. A similar pattern has been 
observed for striatal naloxone-binding sites (Kent et al., 1982). 
100 
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Figure 7. Representative displacement curves for the isotopic dilution of 0.1 nM 3H-DAG0 (0), 1 nM 3H-DADL (A) (in the presence of 10 nM DAGO), and 
1 nM ‘H-EKC (Cl) (in the presence of 100 nM DADL and 100 nM FK33824) determined for day 7 (left) and adult (right) crude forebrain homogenates. At 
each age, similar 12.point displacement curves were generated in three separate experiments performed in duplicate and were analyzed to determine 
affinities and binding capacities. 
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TABLE I 
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Estimated Kd values for DAGO, DADL, and EKC binding to rat brain membranes during postnatal development’ 
EKC 
Age DAGO DADL Forebrain Hindbrain 
Site 1 Site 2 Site 1 Sate 2 
1 0.557 +- 0.031 14.12 k 2.29 3.83 f 1.33 382 f 151 
4 0.629 + 0.021 4.01 f 1.22 
5 4.62 + 0.65’ 357 + 78’ 
7 0.569 + 0.026 5.64 f 1.02 2.31 f 0.59 276 3~ 73 
10 0.530 + 0.016 3.57 f 0.56 4.54 f 0.69 268 & 151 
14 0.665 f 0.035 1.45 f 0.16 1.30 + 0.40 125 + 27 
21 0.615 iz 0.029 1.47 f 0.24 6.59 k 0.93 
28 0.687 + 0.021 2.19 + 0.27 3.55 + 0.76’ 390 f 83b 
35 5.44 f 0.93 634 f 113 
2.16 + 0.52 
3.82 f 0.33b 
1.86 f 0.25 
4.41 f 0.52 
3.50 f 0.50 
4.86 f 1.30 
9.94 f 3.4b 
6.03 it l.ld 
Adult 0.665 + 0.016 1.09 * 0.10 1.58 + 0.83” 772 f 440’ 1.94 -c 0.46” 
1160+610 
941 * 254b 
303 + 68 
2170 f 2080 
649 f 189 
456 f 306 
838 + 226’ 
618 f 76 
316 zk 78’ 
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Figure 2. The ontogeny of 3H-DAG0 
(0) 3H-DADL (A), and high affinity 3H- 
EKC (0) binding capacity in rat forebrain 
expressed as femtomoles bound per 
milligram of wet weight. The binding of 
3H-EKC in the rat hindbrain (brainstem 
and cerebellum) is also presented (0). 
Binding capacity was determined by iso- 
topic dilution (as described in Fig. 1). 
and values reported are the weighted 
mean and SEM of three experiments 
(except where noted in Table I). 
Figure 3. The ontogeny of 3H-DAG0 
(0)m %DADL (A), and high affinity 3H- 
EKC (forebrain, 0; hindbrain, 0) binding 
capacity. The results presented in Figure 
2 are here expressed as femtomoles per 
milligram of protein with the protein per 
assay measured by the method of 
Lowry et al. (1951). 
1 4 7 10 14 21 28 35 Adult 
Age (days) 
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Despite the decline in density, the number of p sites per brain 
continues to rise during the first week after birth. The most pro- 
nounced rate of increase in their levels occurred during the second 
and third weeks postnatal. 
Delta (s) sites. Delta sites, as labeled by 3H-DADL in the presence 
of 10 nM DAGO, are present in only very low levels, if at all, during 
the first week postnatal. From the second through the fourth week 
a nearly linear increase in their concentration occurs. The subse- 
quent appearance in d sites correlates well with the rise of p site 
levels, In addition, we had previously demonstrated that naloxone- 
reversible effects of morphine on striatal catecholamine metabolism 
were not detectable until the end of the first week postnatal (Roth 
et al., 1980). By day 6, a statistically significant rise in striatal, 3,4- 
dihydroxyphenylacetic acid levels was elicited by intraperitoneal 
injection of morphine (10 and 20 mg/kg). Hence, the appearance of 
this effect parallels the rise in cc and 6 receptors observed in forebrain 
in this study (Fig. 2) as well as the elevation of naloxone- and 
enkephalin-binding sites seen in neonatal rat striatum by Kent et al. 
(1982). Indeed, the second week postnatal appears to be one of 
significance to rat brain maturation. Cholinergic (Coyle and Yama- 
mura, 1976) and dopaminergic (Pardo et al., 1977; Morris et al., 
1980; Pittman et al., 1980) receptors also rise sharply at this time. 
Similar to 3H-DAG0, the binding of 3H-DADL did not exhibit an 
improved fit for the two-site model in the time period examined. In 
contrast to 3H-DAG0 binding, the estimated Kd for 3H-DADL was 
not constant but decreased significantly from day 1 to day 10, 
whereupon high affinity binding prevailed until adulthood. In a pre- 
vious investigation (Wohltmann et al., 1982) we demonstrated that 
with DADL as radioligand, the I& for morphine increased with age 
after birth. During early development, morphine displaced 3H-DADL 
with high affinitiy, whereas later in this period, morphine only weakly 
competed with this radioligand. Since the lCsO for morphine in the 
first week was relatively low in the initial study, it was clear that 3H- 
DADL was binding to p sites. In the present investigation a F site 
suppressor was used with 3H-DADL, essentially eliminating binding 
to this site. On the basis of binding capacities (Fig. 2) one might 
speculate that in the present study DADL is binding to K sites during 
the first week after birth. However, DADL has a much lower affinity 
for K sites in adult rat brain (Pfeiffer and Herz, 1982). It is also 
possible that l-week-old rat forebrain contains newly synthesized, 
incompletely processed d receptors (Roth et al., 1981). This hypoth- 
esis may be linked to the observation that rat striatal adenylate 
cyclase activity is not detectable until the second postnatal week 
(Pardo et al., 1977). Perhaps the d receptor may require guanine 
nucleotide-binding protein and cyclase for high affinity binding (Kent 
et al., 1982). 
Kappa (K) sites. EKC binding affinity remained unchanged (within 
experimental error) during development, reflecting its binding to the 
same type of opioid receptors. However, the binding data fit a two- 
site better than a one-site model. Since the affinity for the second 
site was very low (Table I), limited binding to other types of opioid 
receptors may have contributed to this value despite the presence 
of the unlabeled suppressors, 100 nM DAGO and 100 nM DADL. 
However, the possibility that two-site binding is brought about by 
the use of a racemic ligand cannot be excluded. 
The K receptors displayed a differential pattern in fore- and 
hindbrain (Fig. 3). The initial densities at day 1 for both fore- and 
hindbrain were about the same, whereupon hindbrain levels rose 
substantially. After day 14, the density of forebrain K sites increases 
and hindbrain levels appear to decline (Fig. 2). The decrease in 
hindbrain density may be caused by the growth of the cerebellum, 
a region containing fewer K sites (data not shown). These results 
accentuate the desirability of careful regional studies in the future. 
Finally, the caudal-to-rostra1 development seen for these K sites has 
been observed repeatedly for other types of opioid receptors (Coyle 
and Pert, 1976; Tsang and Ng, 1980; Bardo et al., 1982; Tsang et 
al., 1982) and neurotransmitters (Tsang et al., 1982). 
Ontogenic variations in opioid receptors are often expressed in 
femtomoles per milligram of protein (Clendeninn et al., 1976; Tsang 
and Ng, 1980; Tsang et al., 1982) but rarely has the developmental 
pattern been compared with that of brain protein synthesis. In 
agreement with previous data (Pardo et al., 1977) we found the 
postnatal developmental profile of forebrain protein (milligrams of 
protein per milligram of wet weight) to be sigmoidal, with the most 
pronounced increase occurring between days 7 and 28. This time 
interval correlates well with the period of rapid development of p 
and 6 sites. It is then of interest to compare changes in the numbers 
of opioid receptor types with respect to protein concentration, Of 
the three sites investigated, the fluctuations of the 6 receptors parallel 
the changes in protein content most closely. Conversely, by day 14, 
the concentration of ~1 sites (femtomoles per milligram of protein) 
levels off, while protein synthesis continues to increase. 
These results take on added significance in light of recent discov- 
eries of trophic effects upon administration of opiates to neonates. 
Agonists inhibited neurobiological development whereas antagonists 
increased brain size and the numbers of naloxone-binding sites, 
neuronal cells, and glial cells (Slotkin et al., 1980; Zagon and 
McLaughlin, 1983). Since it has been reported that both agonists 
and antagonists also alter levels of opioid receptors in discrete 
regions of neonatal rat brain under similar conditions, it is possible 
that these trophic effects are receptor mediated (Bardo et al., 1982; 
Handelmann, 1983; Handelmann and Quirion, 1983). 
Levels of enkephalins, P-endorphin, and dynorphins have been 
monitored during development by radioimmunochemical methods 
(Bayon et al., 1979; Patey et al., 1980; Tsang et al., 1982; Khatch- 
aturian et al., 1983) with inconsistent results. All three types of opioid 
peptides are present during embryonic development and increase 
after birth. The major discrepancy appears to be whether they 
increase, decrease, or remain the same in the second week post- 
natal. More than likely, these variations reflect differences in regions 
examined (Bayon et al., 1979). Until this issue is resolved, however, 
no definitive conclusions can be drawn concerning a correlation 
between postnatal changes of opioid peptides and their receptors. 
Nevertheless, the fact that opioid peptide levels generally increase 
prior to the elevation of cc and 6 sites in the second week postnatal 
is consistent with the attractive hypothesis that these neuropeptides 
play a role in the development of their receptors. 
The results on the ontogeny of 6 sites complement and corrobo- 
rate earlier work (Kent et al., 1982; Wohltmann et al., 1982; Tsang 
et al., 1982) whereas the data on the cc and K receptors represent 
new and interesting findings. In general, the site selectivity afforded 
by the assay conditions of the present study provided data that 
represent an improvement over the results previously obtained in 
developmental binding experiments. The more specific K assay, for 
example, is clearly superior to the use of EKC or bremazocine alone 
(Gillan and Kosterlitz, 1982). As a result, the developmental profile 
shown here (Fig. 2) is quite different from that obtained using 3H- 
EKC alone (Spain et al., 1983). Understandably, our earlier findings 
reflected the binding of EKC to sites other than K. Recently, using 
less site-specific assay conditions, Leslie et al., (1982) reported that 
a p-specific ligand was less efficient in displacing 3H-EKC binding 
to 6-day-old rat brain membranes than in displacing binding to those 
of adults. However, they could not conclude whether cc sites in- 
creased or K sites decreased in this time period. The results obtained 
in this study prove the former is the case. 
Similarly, the use of ligands that exhibit cross-reactivity can lead 
to ambiguities regarding the absolute concentrations of p and 6 
sites. Previous investigations on the developmental profile of specific 
binding of tritiated [D-ala’-met5]enkephalinamide (Patey et al., 1980; 
Zhang and Pasternak, 1981) met-enkephalin (Tsang and Ng, 1980; 
Tsang et al., 1982) DADL (Kent et al., 1982) and naloxone (Coyle 
and Pert, 1976; Kent et al., 1982) in neonatal rat brain yielded 
patterns similar to that observed in the present study for 6 and p 
sites. However, since the affinity constants were not measured in 
those studies, when low levels of specific binding were determined 
it was not certain whether the desired sites were actually being 
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measured (Wohltmann et al., 1982). In fact, with the exception of an 
early study with 3H-naltrexone (Clendeninn et al., 1976) this is the 
only investigation in which binding affinities and individual concen- 
trations of cc, 6, and K sites were measured over an extended time 
course in the neonatal period. 
In summary, it is clear that the three types of opioid receptors 
examined display differential postnatal development providing inde- 
pendent evidence for multiplicity previously demonstrated by phar- 
macologic (Martin et al., 1976) anatomical (Pert et al., 1976; Chang 
et al., 1979; Goodman et al., 1980) and biochemical (Chang and 
Cuatrecasas, 1979; Kosterlitz et al., 1981; Pfeiffer and Herz, 1982) 
experimentation. 
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